Type B Lactic Acidosis As a Severe Metabolic Complication in Lymphoma and Leukemia

Medicine ◽  
2007 ◽  
Vol 86 (4) ◽  
pp. 225-232 ◽  
Author(s):  
Allison S. Friedenberg ◽  
Douglas E. Brandoff ◽  
Fred J. Schiffman
2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Marco Mejia ◽  
Ariel Perez ◽  
Harold Watson ◽  
Daniel Sanchez ◽  
Jorge Parellada ◽  
...  

Type B lactic acidosis is a rare metabolic complication sometimes associated with hematologic malignancies. When present, this type of lactic acidosis is most commonly seen in patients with high-grade lymphomas or leukemias and is usually indicative of a dismal prognosis. We report a case of a 27-year man with acquired immunodeficiency syndrome (AIDS) that presented with bilateral lower extremity swelling, an abdominal mass, and weight loss. His lab values showed elevated anion gap with lactic acidosis and computed tomography (CT) of the abdomen showed a large soft-tissue mass arising from the left hepatic lobe. Biopsy of the abdominal mass demonstrated a high-grade diffuse large B-cell lymphoma. The patient’s lactic acidosis resolved after starting chemotherapy, and a complete response was evident on PET-CT after a third cycle of rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOC-RR). Care-givers should be aware of the implications of lactic acidosis associated with malignancy and the need for prompt diagnosis and treatment.


2020 ◽  
Vol 13 (3) ◽  
pp. e233068
Author(s):  
Qiuying Selina Liu ◽  
Farzana Harji ◽  
Anna Jones ◽  
Amy C Tarnower

Type B lactic acidosis is a rare metabolic complication of malignancy, more commonly in haematological malignancies. Due to the lack of formal prospective trials, treatment of lactic acidosis associated with malignancy is based on case reports. Given the poor prognosis, early recognition of type B lactic acidosis and prompt treatment are crucial. We report the first case of type B lactic acidosis in metastatic melanoma, followed by a brief literature review on the proposed pathophysiology and treatment.


2021 ◽  
pp. 1159-1167
Author(s):  
Zainab Al Maqrashi ◽  
Mary Sedarous ◽  
Avinash Pandey ◽  
Catherine Ross ◽  
Ahraaz Wyne

Lactate is a byproduct of anaerobic glycolysis, and hyperlactatemia is commonly seen in critically ill patients. We report a case of an elderly male presenting with undifferentiated constitutional symptoms, anemia, thrombocytopenia, severe lactic acidosis, refractory hypoglycemia, and a newly detected abdominal mass. A dedicated workup ruled out infectious etiologies and revealed metastatic non-Hodgkin’s lymphoma. This study explores etiologies of type B lactic acidosis in oncology patients, with a focus on Warburg’s effect, and its potential for prognostication.


Kidney Cancer ◽  
2017 ◽  
Vol 1 (1) ◽  
pp. 83-88 ◽  
Author(s):  
Erica Nakajima ◽  
Paul Leger ◽  
Ingrid A. Mayer ◽  
Michael N. Neuss ◽  
David D. Chism ◽  
...  

2018 ◽  
Vol 46 (1) ◽  
pp. 267-267
Author(s):  
Gautam Phadke ◽  
Dubert Guerrero ◽  
Avish Nagpal ◽  
Hasrat Khan ◽  
Mazen Kherallah ◽  
...  

2020 ◽  
Vol 13 (3) ◽  
pp. e233941
Author(s):  
Sanjeev Khera ◽  
Suman Kumar Pramanik ◽  
Suprita Kalra ◽  
Aradhana Dwivedi

Lactic acidosis (LA) is characterised by persistently increased blood lactate >5 mmol/L. Type A LA due to anaerobic glycolysis is frequently seen during management of haematological malignancies. A rare form of LA known as type B LA, which occurs as a result of metabolic dysregulation at cellular level has been described recently. This has been reported to be because of Warburg effect (WE) or aerobic glycolysis, which is seen in cancerous cells as they rely on aerobic glycolysis rather than oxidative phosphorylation for energy generation. Presence of type B LA at initial presentation of haematological malignancies is a poor prognosticating factor and has rarely been reported in children. We present a child with T cell acute lymphoblastic leukaemia with mild phenotype of type B LA due to WE. She responded dramatically to definitive chemotherapy and tolerated intensive phase of chemotherapy without any significant morbidity.


Sign in / Sign up

Export Citation Format

Share Document